Concepedia

Ole‐Petter R. Hamnvik

OR

Statistics

Publications

20

Citations

1.1K

H-Index

18

Active since

2009

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Beth Israel Deaconess Medical Center

VA Boston Healthcare System

Dana-Farber Cancer Institute

Ole‐Petter R. Hamnvik is an author at Brigham and Women's Hospital specializing in medicine, metabolism, and metabolic syndrome.

ORCID

Top concepts

Publications per year

2009–2020

20

Publications

20

Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway

Ole‐Petter R. Hamnvik, Toni K. Choueiri, Alexander Turchin et al. · Cancer · 2014 · 202 citations · Full text

Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma

Rana R. McKay, Gustavo E. Rodriguez, Xun Lin et al. · Clinical Cancer Research · 2015 · 132 citations · Full text

Comparison of Gonadotropin-Releasing Hormone Agonists and Orchiectomy

Maxine Sun, Toni K. Choueiri, Ole‐Petter R. Hamnvik et al. · JAMA Oncology · 2015 · 118 citations · Full text

Morbidity and mortality in patients with craniopharyngioma after surgery

Rachel Crowley, Ole‐Petter R. Hamnvik, E. P. O’Sullivan et al. · Clinical Endocrinology · 2010 · 106 citations · Full text

Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort

Dorothee M. Baur, Jens Klotsche, Ole‐Petter R. Hamnvik et al. · Metabolism · 2010 · 87 citations

, , +9

1–5 of 20